7 results match your criteria: "IRCCS Azienda Ospedaliero-Universitaria di Bologna S. Orsola Hospital[Affiliation]"
Healthcare (Basel)
December 2023
Pediatric Oncology and Hematology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna S. Orsola Hospital, 40138 Bologna, Italy.
Radiol Cardiothorac Imaging
December 2022
Center for Academic Medicine, Department of Radiology (D.M., M.J.W., V.L.T., V.H., M.C., A.M.S., K.B., D.F.), Stanford Cardiovascular Institute (D.M., M.P.F., D.F.), and Department of Cardiothoracic Surgery (D.C.M., M.P.F.), Stanford University School of Medicine, 453 Quarry Rd, MC 5659, Palo Alto, CA 94304-5659; Departments of Medical Imaging (K.H.) and Surgery (M.O.), Toronto General Hospital, University of Toronto, Toronto, Canada; Department of Radiology (D.O.T.) and Department of Cardiothoracic and Vascular Surgery (R.O.A.), McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, Tex; Department of Radiology, Massachusetts General Hospital, Boston, Mass (S.H.); Departments of Radiology (N.S.B.) and Cardiac Surgery (B.Y.), University of Michigan, Ann Arbor, Mich; Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pa (J.M.L.); Division of Cardiac Surgery, University of Maryland, Baltimore, Md (T.G.G.); Departments of Cardiac Surgery (D.P., G.F.) and Radiology (L.L.), IRCCS Azienda Ospedaliero-Universitaria di Bologna S. Orsola Hospital, Bologna, Italy; Department of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland (R.H., H.A.); Department of Radiology and Imaging Sciences, Emory University, Atlanta, Ga (A.E.S.); Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, NC (E.P.C.); and Department of Clinical Epidemiology and Medical Technology Assessment (S.M.J.v.K.) and Department of Surgery (G.W.H.S.), Maastricht University Medical Center, Maastricht, the Netherlands.
Purpose: To describe the design and methodological approach of a multicenter, retrospective study to externally validate a clinical and imaging-based model for predicting the risk of late adverse events in patients with initially uncomplicated type B aortic dissection (uTBAD).
Materials And Methods: The Registry of Aortic Diseases to Model Adverse Events and Progression (ROADMAP) is a collaboration between 10 academic aortic centers in North America and Europe. Two centers have previously developed and internally validated a recently developed risk prediction model.
Ther Adv Endocrinol Metab
May 2022
Division of Gynecology and Physiopathology of Human Reproduction, Department of Medical and Surgical Sciences (DIMEC), IRCCS Azienda Ospedaliero-Universitaria Di Bologna. S. Orsola Hospital, University of Bologna, Via Massarenti 13, 40138.
Bone health in transmen and transwomen is an important issue that needs to be evaluated by clinicians. Prior to gender-affirming hormone treatment (GAHT), transwomen have lower bone mineral density (BMD) and a higher prevalence of osteopenia than cismen probably related to external factors, such as hypovitaminosis D and less physical activities. Gonadotropin-releasing hormone (GnRH) analogues in transgender youth may cause bone loss; however, the addition of GAHT restores or at least improves BMD in both transboys and transgirls.
View Article and Find Full Text PDFInt J Gynaecol Obstet
December 2022
Gynecology and Obstetrics Unit, Department of Medicine, Surgery and Dentistry "Schola Medica Salernitana", University of Salerno, Baronissi, Italy.
Although Tao brush has become one of the most studied and used endometrial cytological samplers, concerns remain about the adequacy of the cytological sample compared with definitive histology. We aimed to assess accuracy of cytological examination from Tao brush sampling in diagnosing endometrial premalignancy and malignancy through a systematic review and meta-analysis. Seven electronic databases were searched from January 2000 to July 2021 for all studies which allowed assessment of accuracy of Tao brush in diagnosing endometrial premalignancy and malignancy.
View Article and Find Full Text PDFInt J Environ Res Public Health
March 2022
Gynecology and Obstetrics Unit, Department of Medicine, Surgery and Dentistry "Schola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.
Background: In endometrial carcinoma (EC) patients, sentinel lymph node (SLN) biopsy has shown the potential to reduce post-operative morbidity and long-term complications, and to improve the detection of low-volume metastasis through ultrastaging. However, while it has shown high sensitivity and feasibility in low-risk EC patient groups, its role in high-risk groups is still unclear.
Aim: To assess the role of SLN biopsy through the cervical injection of indocyanine green (ICG) in high-risk groups of early-stage EC patients.
Gynecol Oncol
April 2022
Gynecology and Obstetrics Unit, Department of Medicine, Surgery and Dentistry "Schola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.
Background: The 2020 ESGO/ESTRO/ESP guidelines stratify the prognosis of endometrial carcinoma (EC) patients combining The Cancer Genome ATLAS (TCGA) molecular signature and pathological factors, including lymphovascular space invasion (LVSI). However, little is known about the prognostic independence of LVSI from molecular signature.
Aim: To assess whether the prognostic value of LVSI is independent from the TCGA signature.
Gynecol Oncol
August 2021
Division of Gynaecology and Human Reproduction Physiopathology, Department of Medical and Surgical Sciences (DIMEC)., IRCCS Azienda Ospedaliero-Universitaria di Bologna. S. Orsola Hospital. University of Bologna, Via Massarenti 13, Bologna 40138, Italy.
Background: 2021 ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma (EC) encourage molecular classification and propose a new prognostic risk stratification based on both pathologic and molecular features. Although deep myometrial invasion (DMI) has been considered as a crucial risk factor in EC, it is unclear if its prognostic value is independent from The Cancer Genome ATLAS (TCGA) groups.
Aim: To assess if the prognostic value of DMI is independent from the TCGA groups in EC patients.